Skip to content
Open access

Triglyceride-Glucose Index and Systemic Inflammatory Markers in Polyendocrine Metabolic Ovarian Syndrome (Polycystic Ovary Syndrome): A Cross-Sectional Study

Oct 2026 · Metabolites · Vol 16 · 0 citations · 36 references
Medicine

Abstract

Highlights What are the main findings? In women with polyendocrine metabolic ovarian syndrome (PMOS), the triglyceride-glucose (TyG) index was independently associated with hemogram-derived inflammatory indices after adjustment for body mass index (BMI) and age, whereas C-reactive protein (CRP) was associated only with BMI. Both the triglyceride and glucose components contributed, and fasting insulin was only weakly related to these indices. The TyG-inflammation association was consistent across BMI strata, with no evidence of effect modification by BMI in formal interaction tests. What are the implications of the main findings? TyG and hemogram-derived indices, obtained from routine and inexpensive laboratory tests, capture a metabolic-inflammatory signal in PMOS that, in this cohort, is independent of adiposity and is also present in normal-weight women. CRP alone may be insufficient to represent the metabolic–inflammatory axis in PMOS; whether TyG-associated inflammation carries prognostic value requires prospective evaluation against clinical outcomes. Abstract Background/Objectives: Low-grade chronic inflammation is recognized as part of the systemic profile of polyendocrine metabolic ovarian syndrome (PMOS, formerly polycystic ovary syndrome, PCOS), although whether this inflammatory signal tracks insulin resistance, adiposity, or both remains unclear. This study evaluated whether the triglyceride-glucose (TyG) index, a surrogate of insulin resistance, is associated with subclinical inflammation independently of body mass index (BMI) in women with PMOS. Methods: In this retrospective cross-sectional study of 150 women with PMOS, the TyG index was calculated from fasting triglycerides and glucose. C-reactive protein (CRP; standard assay) and the systemic immune–inflammation index (SII) were pre-specified primary markers; the neutrophil-, platelet-, and monocyte-to-lymphocyte ratios (NLR, PLR, and MLR) and the systemic inflammation response index (SIRI) were secondary. Associations were assessed using Spearman correlation and multivariable linear regression adjusted for age and BMI, with component, extended-adjustment, tertile, and BMI-interaction analyses. Results: The TyG index correlated with the homeostatic model assessment of insulin resistance (HOMA-IR) (rho = 0.45, p < 0.001) but not with BMI (rho = 0.03, 95% confidence interval [CI] −0.13 to 0.19, p = 0.71). After adjustment, each standard deviation (SD) increment in TyG was associated with a 21.7% higher SII (95% CI 17.0 to 26.6%; p < 0.001) and with a higher NLR, PLR, MLR, and SIRI (all corrected p ≤ 0.023), with no TyG × BMI interaction. Both triglyceride and glucose components contributed, fasting insulin was only weakly associated, and results were unchanged after further adjustment for hormonal and glycemic covariates. TyG was not associated with CRP (p = 0.53), which was associated only with BMI. Conclusions: In PMOS, the TyG index was associated with hemogram-derived inflammatory indices independently of BMI, a signal attributable to its triglyceride and glucose components rather than to fasting insulin, whereas standard-assay CRP tracked adiposity. These cross-sectional findings are hypothesis-generating.

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.